The Notch signaling pathway is highly conserved and essential for animal development. It is required for cell differentiation, survival, and proliferation. Regulation of Notch signaling is a crucial process for human health.
Ligands initiate a signal cascade by binding to
Notch receptors expressed on a neighboring cell.
Notch receptors interact with
ligands through their
epidermal growth factor-like repeats (
EGF repeats). Most
EGF repeats are modified by O-glycosylation with residues such as O-linked
N-acetylglucosamine (O-GlcNAc), O-
fucose, and O-
glucose. These O-
glycan modifications are important for Notch function. Defects in O-glycosylation affect Notch-
ligand interaction, trafficking of
Notch receptors, and Notch stability on the cell surface. Although the roles of each modification are not fully understood, O-
fucose is essential for binding of
Notch receptors to their
ligands. We reported an
EGF domain-specific
O-GlcNAc transferase (EOGT) localized in the endoplasmic reticulum. Mutations in genes encoding EOGT or NOTCH1 cause
Adams-Oliver syndrome. Dysregulation of Notch signaling because of defects or mutations in
Notch receptors or Notch signal-regulating
proteins, such as
glycosyltransferases, induce a variety of
congenital disorders. In this review, we discuss O-glycosylation of
Notch receptors and congenital human diseases caused by defects in O-
glycans on
Notch receptors.